Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Fosrenol launched in U.K.

Feb. 23, 2007

Ability of N-acetylcysteine to prevent acute renal failure in hypotensives unclear

Feb. 19, 2007

New treatment option for urological disorders disclosed in recent Ranbaxy patent

Feb. 15, 2007

Phase II trial of phosphate binder ILY-101 completes enrollment

Feb. 9, 2007

NX-1207 attracts licensing offers

Feb. 5, 2007

Osprey secures financing to advance OPL-CCL2-LPM into clinic

Feb. 5, 2007

Phase IIb study begins for ozarelix in BPH

Jan. 29, 2007

Fresenius seeks approval for PhosLo in patients with Stage 4 chronic kidney disease

Jan. 25, 2007

Recent Janssen and Aska patents report new therapeutic agents for urological disorders

Jan. 23, 2007

MN-001 shows no statistically significant improvement in interstitial cystitis

Jan. 19, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...